Publications by authors named "Denise Barrow"

Claim this Profile
4
4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitors.
Ahmed G Eissa, Denise Barrow, Julia Gee, Lauren E Powell, Paul A Foster

Eur J Med Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
Iain R Hutcheson, Janice M Knowlden, Steve E Hiscox, Denise Barrow, Julia M W Gee

Breast Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.
Nicola J Jordan, Carol M Dutkowski, Denise Barrow, Huw J Mottram, Iain R Hutcheson

Breast Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
Janice M Knowlden, Julia M W Gee, Denise Barrow, John F Robertson, Ian O Ellis

Breast Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.
Julia M W Gee, Robert I Nicholson, Denise Barrow, Carol M Dutkowski, Lindy Goddard

Horm Mol Biol Clin Investig· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.
Iain R Hutcheson, Lindy Goddard, Denise Barrow, Richard A McClelland, Hayley E Francies

Breast Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Janice M Knowlden, Helen E Jones, Denise Barrow, Julia M W Gee, Robert I Nicholson

Breast Cancer Res Treat· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
Iain R Hutcheson, Janice M Knowlden, Steve E Hiscox, Denise Barrow, Julia M W Gee

Breast Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth factor receptor interplay and resistance in cancer.
Helen E Jones, Julia M W Gee, Iain R Hutcheson, Janice M Knowlden, Denise Barrow

Endocr Relat Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy.
Iain R Hutcheson, Janice M Knowlden, Helen E Jones, Rajpal S Burmi, Richard A McClelland, Denise Barrow

Endocr Relat Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
Stephen Hiscox, Liam Morgan, Tim P Green, Denise Barrow, Julia Gee

Breast Cancer Res Treat· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.
Gabriella De Martino, Michael C Edler, Giuseppe La Regina, Antonio Coluccia, Maria Chiara Barbera, Denise Barrow

J Med Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.
Stephen Hiscox, Wen Go Jiang, Kathrin Obermeier, Kathryn Taylor, Liam Morgan, Denise Barrow

Int J Cancer· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).
Stephen Hiscox, Liam Morgan, Denise Barrow, Carol Dutkowskil, Alan Wakeling

Clin Exp Metastasis· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells.
Nicola J Jordan, Julia M W Gee, Denise Barrow, Alan E Wakeling, Robert I Nicholson

Breast Cancer Res Treat· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biology of antihormone failure in breast cancer.
Robert I Nicholson, Julia M W Gee, Janice Knowlden, Richard McClelland, Tracie-Ann Madden, Denise Barrow

Breast Cancer Res Treat· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination.
Robert I Nicholson, Iain R Hutcheson, Janice M Knowlden, Helen E Jones, Maureen E Harper, Denise Barrow

Clin Cancer Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
Iain R Hutcheson, Janice M Knowlden, Tracie-Ann Madden, Denise Barrow, Julia M W Gee

Breast Cancer Res Treat· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.
Janice M Knowlden, Iain R Hutcheson, Helen E Jones, Tracieann Madden, Julia M W Gee, Denise Barrow

Endocrinology· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.
Maureen E Harper, Lindy Goddard, Eve Glynne-Jones, Jean Assender, Carol M Dutkowski, Denise Barrow

Prostate· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis